UBT251 Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
ObesityOverweight
Novo Nordisk A/S333 enrolled3 locationsNCT07395687
Recruiting
Phase 2
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Metabolic dysfunction-associated steatohepatitis (MASH)
The United Bio-Technology (Hengqin) Co., Ltd.156 enrolled1 locationNCT07145151
Recruiting
Phase 2
UBT251 Injection Phase II Clinical Study (CKD)
Chronic Kidney DiseaseObesity &Amp; Overweight
The United Bio-Technology (Hengqin) Co., Ltd.180 enrolled1 locationNCT07134335